Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health plan

Acta Cytologica

Volumn 49, Issue 4, 2005, Pages 391-397

  Sawaya, George F ^a   Sung, Hai Yen ^b,c   Kinney, Walter ^d   Kearney, Kathleen A ^e   Miller, Marie G ^f   Hiatt, Robert A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAISER PERMANENTE   (United States)

^e Kearney Consulting   (United States)

^f NONE

Author keywords

Cervical cancer; Mass screening; Papanicolaou smear

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; DIAGNOSTIC TEST; FEMALE; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SCREENING TEST; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

EID: 22444431718     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326172     Document Type: Article

References (29)

1. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK: SEER Cancer Statistics Review, 1973-1994. Bethesda, National Cancer Institute, 1997
2. Sawaya GF, Brown AD, Washington AE, Garber AM: Current approaches to cervical-cancer screening. N Engl J Med 2001; 344:1603-1607
3. Recommendations on cancer screening in the European union: Advisory Committee on Cancer Prevention. Eur J Cancer 2000;36:1473-1478
4. US Preventive Services Task Force: Cervical cancer screening. Accessed January 8, 2004, at http://www.ahrq.gov/clinic/uspstf/uspscerv.htm
5. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C: American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. CA Cancer J Clin 2002;52:342-362
6. Cervical Cytology Screening. Available at http://www.ncbi. nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d opt=Citation&list_uids=14631934
7. Miller MG, Sung H, Sawaya GF, Kearney KA, Kinney W, Hiatt RA: Screening interval and risk of invasive squamous-cell cervical cancer: A case-control study among long-term members of a large prepaid health plan. Obstet Gynecol 2003;101: 29-37
8. Kinney WK, Miller M, Sung H, Sawaya GF, Kearney KA, Hiatt RA: Risk of invasive squamous carcinoma of the cervix associated with screening intervals of 1, 2, and 3 years: A case-control study (abstr). Obstet Gynecol (suppl) 2001;97-S3
9. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA: Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000;88:2283-2289
10. Nieminen P, Kallio M, Hakama M: The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 1995;85:1017-1021
11. Platz CE, Benda JA: Female genital tract cancer. Cancer (suppl) 1995;75:270-294
12. Chan PG, Sung HY, Sawaya GF: Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Available at http://www.ncbi.nlm.nih.gov/entrez/query. fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list_uids =14551007
13. http://seer.cancer.gov/seerstat/WebHelp/SeerstatAlgorithms_ for_Rates.htm
14. Mantel N: Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
15. Fleiss JL: Statistical Methods for Rates and Proportions. Second edition. New York, John Wiley & Sons, 1981
16. Anderson GH, Benedet JL, Le RJ, Matisic JP, Thompson JE: Invasive cancer of the cervix in British Columbia: A review of the demography and screening histories of 437 cases seen from 1985-1988. Obstet Gynecol 1992;80:1-4.
17. Janerich DT, Hadjimichael O, Schwartz PE, Lowell DM, Meigs JW, Merino MJ, Flannery JT, Polednak AP: The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health 1995;85:791-794
18. Nasca PC, Ellish N, Caputo TA, Saboda K, Metzger B: An epidemiologic study of Pap screening histories in women with invasive carcinomas of the uterine cervix. N Y State J Med 1991; 91:152-156
19. Rolnick S, LaFerla JJ, Wehrle D, Tiygstad E, Okagaki T: Pap smear screening in a health maintenance organization: 1986-1990. Prev Med 1996;25:156-161
20. Wain GV, Farnsworth A, Hacker NF: The Papanicolaou smear histories of 237 patients with cervical cancer. Med J Aust 1992; 157:14-16
21. Schwartz PE, Hadjimichael O, Lowell DM, Merino MJ, Janerich D: Rapidly progressive cervical cancer: The Connecticut experience. Am J Obstet Gynecol 1996;175:1105-1109
22. Stenkvist B, Soderstrom J: Reasons for cervical cancer despite extensive screening. J Med Screen 1996;3:204-207
23. Lynge E, Poll P: Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982. IARC Sci Publ 1986;1986:69-86
24. Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE: Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. Available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list_uids=14561792
25. Krieger N: Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 1992;82:703-710
26. Kim JJ, Wright TC, Goldie SJ: Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390
27. Maxwell G, Carlson J, Ochoa M, Krivak T, Rose G, Myers E: Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. Obstet Gynecol 2002; 100:740-748
28. Brown AD, Garber AM: Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing. JAMA 1999;281: 347-353
29. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K: Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002;287:2372-2381